JFL Life Sciences Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
JFLLIFE Fair Value Analysis — Data Sources & Coverage
JFL Life Sciences financial data sources, valuation methods applied and sector benchmarks used. Read JFLLIFE dividend yield for the complete payout history and dividend yield track record.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
JFLLIFE vs Healthcare Sector Peers — P/E, P/B & Market Cap
JFL Life Sciences P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Aurobindo Pharma | AUROPHARMA | 25.88 | 2.53 | ₹96,652 |
| Sat Kartar Life | SATKARTAR | 13.37 | 3.34 | ₹226 |
| Divis Laboratories | DIVISLAB | 85.36 | 14.9 | ₹247,470 |
| Syngene International | SYNGENE | 69.95 | 3.2 | ₹15,307 |
| Emcure Pharmaceuticals | EMCURE | 36.8 | 7.52 | ₹37,799 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.